|
Real-time Estimate
Cboe BZX
14:37:45 03/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.430 USD | 0.00% |
|
-4.33% | -17.63% |
| 08-18 | Cellectar Biosciences, Inc. - Special Call | |
| 08-13 | Cellectar Biosciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 22.97M 19.82M 18.67M 17.01M 31.79M 2.17B 32.03M 221M 85.76M 1.11B 86.25M 84.36M 3.64B | P/E 2026 * |
-1x | P/E 2027 * | -1.27x |
|---|---|---|---|---|---|
| Enterprise Value | 22.97M 19.82M 18.67M 17.01M 31.79M 2.17B 32.03M 221M 85.76M 1.11B 86.25M 84.36M 3.64B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 3x |
| Free-Float |
98.25% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CLRB | Delayed | |
CBOE
| CLRB | Real-time |
Last Transcript : Cellectar Biosciences, Inc.
| 1 week | -4.33% | ||
| Current month | -3.19% | ||
| 1 month | -5.45% | ||
| 3 months | -11.31% | ||
| 6 months | -18.73% | ||
| Current year | -17.63% |
| 1 week | 2.42 |  | 2.55 |
| 1 month | 2.42 | | 2.7 |
| Current year | 2.2 | | 4.7 |
| 1 year | 2.2 | | 6.52 |
| 3 years | 2.2 | | 133.5 |
| 5 years | 2.2 | | 319.47 |
| 10 years | 2.2 | | 10,410.01 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Caruso
CEO | Chief Executive Officer | 66 | 14/06/2015 |
Chad Kolean
DFI | Director of Finance/CFO | 60 | 27/05/2014 |
Jarrod Longcor
COO | Chief Operating Officer | 52 | 22/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
John Neis
BRD | Director/Board Member | 69 | 31/01/2008 |
James Caruso
BRD | Director/Board Member | 66 | 14/06/2015 |
Douglas Swirsky
CHM | Chairman | 56 | 31/07/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/07/26 | Free | Director | 15,000 | 0.5603% | ||
| 08/07/26 | Free | Director | 15,000 | 0.5603% | ||
| 07/07/26 | Free | Director | 25,000 | 0.9339% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -4.33% | -49.59% | -95.55% | 22.97M | |
| -0.83% | -2.47% | +57.79% | +108.23% | 1,034B | |
| +0.34% | +1.93% | +54.56% | +71.49% | 663B | |
| -0.09% | -0.45% | +23.50% | +76.60% | 462B | |
| +1.90% | -1.10% | +33.58% | +39.72% | 344B | |
| 0.00% | +6.43% | +28.70% | +49.01% | 307B | |
| +1.16% | +1.29% | +0.49% | +14.78% | 251B | |
| -0.30% | +0.57% | +54.34% | +72.51% | 239B | |
| +1.49% | +4.67% | -15.25% | -52.85% | 207B | |
| +0.40% | +1.03% | +32.74% | +95.19% | 186B | |
| Average | +0.48% | -1.06% | +22.09% | +37.91% | 369.34B | |
| Weighted average by Cap. | +0.23% | -0.84% | +38.78% | +68.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 7.65M 6.6M 6.22M 5.66M 10.59M 723M 10.67M 73.59M 28.56M 369M 28.72M 28.09M 1.21B |
| Net income | -31.63M -27.29M -25.71M -23.42M -43.78M -2.99B -44.11M -304M -118M -1.53B -119M -116M -5.02B | -37.38M -32.24M -30.37M -27.68M -51.73M -3.53B -52.12M -360M -140M -1.81B -140M -137M -5.93B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/09/26 | US$2.430 | -1.22% | 48,766 |
| 01/09/26 | US$2.460 | -1.99% | 46,427 |
| 31/08/26 | US$2.510 | -0.79% | 17,294 |
| 28/08/26 | US$2.530 | -0.39% | 23,836 |
| 27/08/26 | US$2.540 | 0.00% | 10,321 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CLRB Stock
Select your edition
All financial news and data tailored to specific country editions
